J Am Coll Cardiol. 2026 Feb 11:S0735-1097(25)10555-X. doi: 10.1016/j.jacc.2025.11.054. Online ahead of print.
ABSTRACT
Durable left ventricular assist devices (dLVAD) remain a lifesaving therapy in patients with stage D heart failure that is refractory to conventional medical therapies. Owing to improvements in technology and patient outcomes, the number of patients supported with dLVADs has increased over the past decade. Despite this growing population, there are few resources for cardiovascular intensivists that integrate epidemiology, diagnostic workup and multidisciplinary medical management of acute emergencies in patients supported with dLVADs.
PMID:41778952 | DOI:10.1016/j.jacc.2025.11.054